Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
Status:
Terminated
Trial end date:
2020-07-14
Target enrollment:
Participant gender:
Summary
This study will enroll about 66 participants who experienced a relapse of RRMS that steroids
did not help. The doctor will put participants into a treatment group. Each person has an
equal chance of being in either one of two groups (like flipping a coin). One group will
receive a shot of study medicine (called Acthar Gel) under their skin every day for 14 days.
The other group will receive a shot every day for 14 days, too, but there is no medicine in
it (called placebo).